Pacific Capital Partners Ltd
- SEC CIK
- 0002064920
- Latest filing
- Aug 12, 2026
RPRX holding history
Royalty Pharma plc in every 13F filed by Pacific Capital Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −94,750−100.0% | Sold out | Holders |
| Q4 2025 | 94,750 | $3.66M | 3.9% | −5,250−5.3% | Reduced | Holders |
| Q3 2025 | 100,000 | $3.53M | 3.9% | +2,500+2.6% | Added | Holders |
| Q2 2025 | 97,500 | $3.51M | 3.3% | −77,500−44.3% | Reduced | Holders |
| Q1 2025 | 175,000 | $5.45M | 3.4% | +12,500+7.7% | Added | Holders |
| Q4 2024 | 162,500 | $4.15M | 2.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 162,500 | $4.60M | 2.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 162,500 | $4.29M | 2.8% | 00.0% | Unchanged | Holders |
| Q1 2024 | 162,500 | $4.94M | 3.2% | +12,500+8.3% | Added | Holders |
| Q4 2023 | 150,000 | $4.21M | 3.2% | −21,500−12.5% | Reduced | Holders |
| Q3 2023 | 171,500 | $4.65M | 2.8% | – | No prior filing | Holders |